Visalytics
Visalytics
approved EB-2 (NIW)

PhD Student

Biotechnology · Iran · 2025-04-01

Processing Time
12 days
Decision Date
2025-04-01
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing advanced microfluidic systems that integrate precision micro-fabrication with high-resolution imaging to replicate complex human body microenvironments. This work focuses on creating scalable platforms to observe cell behavior in realistic conditions, specifically targeting the study of cancer, neurodegenerative disorders, and antibiotic-resistant infections.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses major challenges in modern medicine, specifically the need for biologically relevant environments to study disease and accelerate drug discovery.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a record of peer-reviewed publications and citations, along with expert testimony confirming his leadership in microfluidic system optimization.

3 Balance of Factors Met

The petitioner's innovations in lab-on-a-chip applications and cancer diagnostics provide meaningful benefits to national scientific and healthcare priorities.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of four peer-reviewed journal articles, including two as first author, and 30 citations indicating academic recognition. The case satisfied all three Dhanasar prongs by demonstrating the national importance of microfluidic systems in drug discovery and the petitioner's technical leadership in optimizing ECRs and bacteria removal systems.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Arizona 62 days 2025-04-16
The petitioner proposes to engineer novel bacterial systems by integrating synthetic biology and microfluidics to create engineered living systems. This work aims to develop self-healing materials and precision drug delivery platforms for biomedical, biomanufacturing, and environmental applications. The research focuses on pioneering microbial innovations to advance the U.S. bioengineering sector.
View Case

Postdoctoral Researcher

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Ohio 112 days 2023-02-07
The petitioner proposes to continue research on utilizing biomedical engineering in cancer research and development to improve health outcomes for patients. The work focuses on nanotechnology for drug delivery, the exploration of circulating tumor cells (CTCs), and the creation of microfluidic models to inform metastasis research.
View Case

Biomedical Engineer

Engineering · China

WeGreened EB-2 (NIW) approved
New York 7 days 2023-12-14
The petitioner proposes to continue research on using microfluidics, organ-on-chip, and 3D bioprinting techniques to develop novel tissue engineering models for the lymphatic and ophthalmic systems. This work aims to identify therapeutic targets for diseases and address the growing demand for tissue engineering solutions and the prevalence of lymphatic and ophthalmic diseases.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 10 days 2023-08-24
The petitioner proposes to investigate novel strategies for diagnosis, drug delivery, and immunotherapy to develop new treatments for cancer. His work focuses on developing the AESOP platform, a microfluidic cell deformation system designed to improve the safety and efficiency of intracellular gene editing delivery.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 12 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist